# FDA Inspection 1270959 - Adhexpharma - June 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/adhexpharma/64d984a5-5e0e-48f9-b927-137b8df0e19c
Source feed: FDA_Inspections

> FDA Inspection 1270959 for Adhexpharma on June 14, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1270959
- Company Name: Adhexpharma
- Inspection Date: 2023-06-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1133602 - 2019-07-19](https://www.keypedia.com/records/fda_inspections/adhexpharma/467582b7-167b-4a77-bbaa-c4afcb87e9c8)
- [FDA Inspection 1008978 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/adhexpharma/81059bad-acb0-4413-ba29-facca491d58c)

Company: https://www.keypedia.com/companies/adhexpharma/5e2a83ac-e438-4282-afb7-53bfc2b03029

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c